BioCentury
ARTICLE | Clinical News

Zostavax regulatory update

May 9, 2005 7:00 AM UTC

MRK submitted a BLA to FDA for Zostavax zoster vaccine to prevent herpes zoster, post-herpetic neuralgia (PHN) and to reduce acute and chronic shingles-associated pain in adults. ...